Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1978 1
1983 1
2000 1
2001 2
2003 1
2004 2
2005 1
2006 2
2007 2
2008 1
2009 2
2010 3
2011 1
2012 4
2013 2
2014 3
2015 7
2016 2
2017 8
2018 6
2019 7
2020 11
2021 13
2022 12
2023 13
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

92 results

Results by year

Filters applied: . Clear all
The following term was ignored: %
The following term was not found in PubMed: 20Furue
Page 1
Announcement: UEDA Heart Awards for 2019.
[No authors listed] [No authors listed] Int Heart J. 2019;60(6):1448. doi: 10.1536/ihj.60-6_UEDA. Int Heart J. 2019. PMID: 31787633 Free article.
FIRST PLACEA Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated CardiomyopathyHiroshi Kawakami, Akiyoshi Ogimoto, Naohito Tokunaga, Kazuhisa Nishimura, Hideo Kawakami, Haruhiko Higashi, Chiharuko Iio, Tamami Kono, Jun Aono, Teruyoshi U …
FIRST PLACEA Novel Truncating LMNA Mutation in Patients with Cardiac Conduction Disorders and Dilated CardiomyopathyHiroshi Kawakami, Akiyos …
Tofogliflozin long-term effects on atherosclerosis progression and major clinical parameters in patients with type 2 diabetes mellitus lacking a history of cardiovascular disease: a 2-year extension study of the UTOPIA trial.
Katakami N, Mita T, Yoshii H, Shiraiwa T, Yasuda T, Okada Y, Kurozumi A, Hatazaki M, Kaneto H, Osonoi T, Yamamoto T, Kuribayashi N, Maeda K, Yokoyama H, Kosugi K, Ohtoshi K, Hayashi I, Sumitani S, Tsugawa M, Ryomoto K, Kato K, Nakamura T, Kawashima S, Sato Y, Watada H, Shimomura I; UTOPIA study investigators. Katakami N, et al. Cardiovasc Diabetol. 2023 Jun 22;22(1):143. doi: 10.1186/s12933-023-01879-4. Cardiovasc Diabetol. 2023. PMID: 37349722 Free PMC article. Clinical Trial.
Phase 3 Clinical Trial Comparing the Safety and Efficacy of Netarsudil to Ripasudil in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension: Japan Rho Kinase Elevated Intraocular Pressure Treatment Trial (J-ROCKET).
Araie M, Sugiyama K, Aso K, Kanemoto K, Iwata R, Hollander DA, Senchyna M, Kopczynski CC. Araie M, et al. Adv Ther. 2023 Oct;40(10):4639-4656. doi: 10.1007/s12325-023-02550-w. Epub 2023 Aug 21. Adv Ther. 2023. PMID: 37603205 Free PMC article. Clinical Trial.
Sitosterol prevents obesity-related chronic inflammation.
Kurano M, Hasegawa K, Kunimi M, Hara M, Yatomi Y, Teramoto T, Tsukamoto K. Kurano M, et al. Biochim Biophys Acta Mol Cell Biol Lipids. 2018 Feb;1863(2):191-198. doi: 10.1016/j.bbalip.2017.12.004. Epub 2017 Dec 6. Biochim Biophys Acta Mol Cell Biol Lipids. 2018. PMID: 29221711 Clinical Trial.
Statement for Appropriate Clinical Use of PCSK9 Inhibitors.
Nohara A, Ohmura H, Okazaki H, Ogura M, Kitagawa K, Koseki M, Sato K, Tsukamoto K, Yamashita S; Japan Atherosclerosis Society Working Group on Statement for Appropriate Use of PCSK9 Inhibitors. Nohara A, et al. J Atheroscler Thromb. 2018 Aug 1;25(8):747-750. doi: 10.5551/jat.45229. Epub 2018 Jun 13. J Atheroscler Thromb. 2018. PMID: 29899173 Free PMC article. No abstract available.
92 results